INSAR Annual Meeting Schedule

INSAR 2019 Annual Meeting Schedule
(as of 4/4/2019)

May 1 - 4
Palais des congres de Montreal 
(Montreal Convention Center)
Montreal, Canada

A schedule at a glance is listed below.  Abstract text is embargoed for the press until the 1 May, 2019 Press Conference.  All events to be held at the Convention Center unless otherwise noted.

Note:  INSAR is a partner for the Autism Neuroimaging Workshop to be held on April 30, 2019 in Montreal.  This event is not included in INSAR Annual Meeting registration.  View the workshop website for details and to register.  Space is limited.  

*All INSAR 2019 events to be held at the Montreal Convention Center unless otherwise noted

Wednesday, May 1, 2019

 

11:00A-7:00P

Registration Open

  11:00A-12:00P
Press Conference
Location:  Westin Hotel - Ramesay Room
Media picks up badges at the Press Conference
     
  12:00P-3:00P Student/Early Career Workshop – pre-registration required, student members only
  12:00P-4:30P
Cultural Diversity
 Workshoppre-registration not required
  3:00P-6:00P

Speaker Ready Room

 

5:00P-6:00P

Cultural Diversity Meet & Greet
Important:Go to INSAR Registration Desk first to get your badge

 

6:00P-7:30P

Opening Reception & Exhibit Hall Open
Important: Go to INSAR Registration Desk first to get your badge

Thursday, May 2, 2019

 

7:30A-6:00P

Registration Open

  7:30A-5:30P
Speaker Ready Room

 

8:00A-9:00A

Coffee & Tea

 

8:00A-5:00P

Exhibits Open

     

 

8:30A-9:00A

Welcome from INSAR 2019 Organizers &
INSAR President Address

 

9:00A-10:00A

Keynote Address - Kathryn Roeder 
De novo Variation in Coding and Noncoding Regions: What We Can Learn from the Data About Etiological Pathways

 

10:00A-10:30A

Break

 

10:30A-12:30P

Concurrent Panel Sessions 

    Cellular Models/Stem Cells:
Stem Cell Based Technologies in Autism Research
    Education:
School-Based Interventions for Children with ASD: Harnessing the Power of Parents and Teachers
    Novel Therapeutic Approaches (gene, protein or RNA targeted therapies):
Cerebellum in Autism: Biomarkers, Mechanisms, and Translational Opportunities
    Postmortem Studies:
Functional Genomic Profiling Studies of ASD Brain
    Sensory, Motor, and Repetitive Behaviors and Interests:
Promise and Limitations of Multi-Modal Measurement of Sensory Processing in Autism
    Technological Approaches:
Innovative Uses of Technology for Autism Screening, Outcome Monitoring, and Treatment

 

11:30A-1:30P

Poster Sessions

    Adult Outcome:
Medical, Cognitive, Behavioral, Social, Adaptive, Vocational; Biomarkers (molecular, phenotypic, neurophysiological, etc); Cognitive Neuroscience; Diagnostic, Behavioral, Sensory and Intellectual Screening and Assessment; Early Development (< 48 months); Education; Epidemiology/Population Studies; Gastrointestinal (GI); International and Cross-Cultural Perspectives; Interventions - Non-pharmacologic - School-Age, Adolescent, Adult; Medical and Psychiatric Comorbidity; Social Cognition and Social Behavior

 

 

Exhibits

 

12:30P-1:30P

Lunch Break (Box Lunches Provided)

 

12:30P-1:30P

Student “Meet the Experts” Luncheon –pre-registration required, student members only

 

12:30P-1:30P

Early Career Committee – Rapid Research Rounds Lunch Session

 

1:30P-3:30P

Concurrent Oral Sessions 

 
Oral 1A - Biomarkers (molecular, phenotypic, neurophysiological, etc):
Biomarkers 1 - Eyetracking
 
Oral 1B - Biomarkers (molecular, phenotypic, neurophysiological, etc):
Biomarkers 2 - Predicting Outcomes
 
Oral 2A - Neuroimaging:
Functional Imaging
 
Oral 2B - Neuroimaging:
Structural Imaging
 
Oral 3A - Medical and Psychiatric Comorbidity:
Comorbidity 1
 
Oral 3B - Medical and Psychiatric Comorbidity:
Comorbidity 2
 
Oral 4A - Interventions - Pharmacologic:
Medication and Technologies
 
Oral 4B - Family Issues and Stakeholder Experiences:
Professional Education and Siblings
 
Oral 5A - Molecular Genetics:
Genomics
 
Oral 5B - Biomarkers (molecular, phenotypic, neurophysiological, etc):
Neuropathology / -omics
 
Oral 6A - Cognition:
Attention, Learning, Memory: Cognition and Motor Control
 
Oral 6B - Social Cognition and Social Behavior:
Socioemotional Functioning

 

3:30P-4:00P

Break

 

4:00P-5:30P

Keynote Address - Lifetime Achievement Award

 

 

INSAR Awards Ceremony – Lifetime Achievement, Advocate Award, Slifka / Ritvo Innovation, Young Investigator, Dissertation, Cultural Diversity Research Award

  5:30P-7:00P Poster Sessions
    Cellular Models/Stem Cells; Cognition: Attention, Learning, Memory; Diagnostic, Behavioral, Sensory and Intellectual Screening and Assessment; Early Development (< 48 months); Family Issues and Stakeholder Experiences; Interventions - Non-pharmacologic - Infant, Toddler, and Preschool; Neuroimaging; Neurology; Neuropsychology; Postmortem Studies; Rare Genetic Disorders; Sensory, Motor, and Repetitive Behaviors and Interests; Social Cognition and Social Behavior; Technological Approaches

 

7:00P

INSAR Student Member Social - Offsite Location TBA

Friday, May 3, 2019

 

8:00A-6:00P

Registration Open

  7:30A-5:30P Speaker Ready Room

 

8:00A-9:00A

Coffee & Tea

 

8:00A-5:00P

Exhibits Open (Last day of exhibits)

     

 

7:15A-8:45A

Concurrent Special Interest Groups (SIGs)

    Clinical Strategies for Including Severely Affected Individuals in Neuroscience Studies
    Autism and Related Disorders in the Context of Humanitarian Emergencies
    Gastrointestinal Issues in Autism Spectrum Disorder Room: 525
    Adapting and Advancing Postsecondary Education for Autistic Students

 

8:45A-9:00A

Welcome & Sponsor Update

 

9:00A-10:00A

Keynote Address - Jason Lerch
Of Many Autisms or One Neurodevelopmental Disorder

 

10:00A-10:30A

Break

 

10:00A-1:30P

Innovative Technologies Demonstration 

 

10:30A-12:30P

Concurrent Panel Sessions

    Adult Outcome:
Medical, Cognitive, Behavioral, Social, Adaptive, Vocational: Health and Well-Being in Transition-Age Youth and Adults with Autism Spectrum Disorder
    Biomarkers (molecular, phenotypic, neurophysiological, etc):
The Multiple Powers of Eye Tracking in Early Developmental Research: From Mechanism to Diagnostic, Prognostic, and Clinical Characterization Utility
    Family Issues and Stakeholder Experiences:
Parents As Mediators of Intervention and Functioning of Children and Adolescents with ASD
    Late Phase Drug Development:
Outcome Measures in Phase 2/3 Trials in ASD
    Molecular Genetics:
Genetic and Genomic Discovery in Autism: From SNPs, to Exomes and Genomes.
    Service Delivery/Systems of Care:
Effectiveness of ASD Evidenced-Based Practices for End-Users: Examination of Child Outcomes in Multiple Community Service Settings

 

11:30A-1:30P

Poster Sessions

    Animal Models; Behavioral Genetics; Behavioral Neuroscience; Cellular Neuroscience; Communication and Language; Diagnostic, Behavioral, Sensory and Intellectual Screening and Assessment; Epigenetics; Interventions - Non-pharmacologic - Infant, Toddler, and Preschool; Family Issues and Stakeholder Experiences; Molecular Neuroscience; Neuroimaging; Sensory, Motor, and Repetitive Behaviors and Interests; Service Delivery/Systems of Care; Social Cognition and Social Behavior; Statistical Genetics

 

 

Exhibits

 

12:30P-1:30P

Lunch Break (Box Lunches Provided)

 

12:30P-1:30P

Student “Meet the Experts” Luncheon –pre-registration required, student members only

 

12:30P-1:30P

Cultural Diversity Networking Luncheon (open - no pre-registration required)

 

12:30P-1:30P

Autism Community Stakeholder Luncheon (open - no pre-registration required)

 

1:30P-3:30P

Concurrent Oral Sessions

    Oral 7A - Early Development (< 48 months):
Screening
 
Oral 7B - Diagnostic, Behavioral, Sensory and Intellectual Screening and Assessment:
Diagnosis
    Oral 8A - Biomarkers (molecular, phenotypic, neurophysiological, etc):
Biomarkers 3
 
Oral 8B - Neurophysiology/Electrophysiology:
Brain EEG
 
Oral 9A - Interventions - Non-pharmacologic - Infant, Toddler, and Preschool:
Early Intervention
 
Oral 9B - Service Delivery/Systems of Care:
Intervention 2
 
Oral 10A - Education:
Education
    Oral 10B - Communication and Language:
Communication and Language
 
Oral 11A - Epidemiology/Population Studies:
Epidemiology
 
Oral 11B - Diagnostic, Behavioral, Sensory and Intellectual Screening and Assessment:
Developmental Trajectories
 
Oral 12A - Adult Outcome:
Medical, Cognitive, Behavioral, Social, Adaptive, Vocational: Adult Outcomes
    Oral 12B - Family Issues and Stakeholder Experiences:
Caregiver Experience/Participatory Research

 

3:30P-4:00P

Coffee Break

 

3:30P-5:00P

Autism Research Author Workshop (pre-registration not required) Room: 516DE

 

3:30P-5:30P

Concurrent Panel Sessions

    Animal Models:
Innovative Outcome Measures Relevant to ASD in Preclinical Models
    Biomarkers (molecular, phenotypic, neurophysiological, etc): 
"Developmental Disconnections" in Infants at Risk for ASD
    Interventions - Non-pharmacologic - School-Age, Adolescent, Adult: Social Skills Training in Autism:
Yesterday's Challenges and Tomorrow's Solutions
    Medical and Psychiatric Comorbidity:
Where Do We Go from Here? Learning How to Prevent Suicide in Partnership with Autistic People and Their Allies.
    Medical and Psychiatric Comorbidity:
Sleep, Circadian Neuroscience, and Autism across the Lifespan
    Neuroimaging:
Advances in Mechanisms of ASD Connectopathy: Multiscale Perspectives
 
5:30P

Introduction & Sponsor Update
 NEW

5:30P-6:30P


Keynote Address - Vikram Patel
From Clinics to Communities:
Addressing Global Disparities in Autism Care

 

5:30P-7:00P

Poster Sessions

    Adult Outcome: Medical, Cognitive, Behavioral, Social, Adaptive, Vocational; Affective Neuroscience; Clinical Genetics; Clinical Trial Design; Clinical Trial Endpoints; Cognition: Attention, Learning, Memory; Communication and Language; Diagnostic, Behavioral, Sensory and Intellectual Screening and Assessment; Drug Discovery and Development; Early Phase Drug Discovery; Immunology; Interventions - Non-pharmacologic - School-Age, Adolescent, Adult; Late Phase Drug Development; Medical and Psychiatric Comorbidity; Molecular Genetics; Neurological Findings; Novel Therapeutic Approaches (gene, protein or RNA targeted therapies); Pediatrics; Service Delivery/Systems of Care; Social Neuroscience

Saturday, May 4, 2019
Note: No exhibits on Saturday this year

 

8:00A-2:00P

Registration

  7:30A-1:30P

Speaker Ready Room

 

8:00A – 9:00A

Coffee & Tea

     

 

7:15A-8:45A

Concurrent Special Interest Groups (SIGs)

    Gender, Sexuality, and Romantic Relationships Room: 519
    Building on Existing Strengths and Lessening Current Barriers to Physical Activity for Autistic Individuals Across the Lifespan
    Memory in Individuals with ASD With and Without Co-occurring Intellectual Disability: Methodological Challenges and Ways to Overcome Them
    Promoting Partnerships Between Patient Advocacy Groups and Researchers to Improve Autism Research
 
8:45A-9:00A

Welcome & Sponsor Update

 

9:00A-10:00A

Keynote Address - Elizabeth Berry-Kravis
Transcending Barriers to Development of Targeted Treatments for Fragile X Syndrome 

 

10:00A-10:30A

Break

 

10:30A-12:30P

Concurrent Panel Sessions

    Biomarkers (molecular, phenotypic, neurophysiological, etc):
Novel Imaging Approaches to Biomarker Discovery in Autism Spectrum Disorder: Recent Findings from the Pond and EU-AIMS Networks
    Biomarkers (molecular, phenotypic, neurophysiological, etc):
Autism Spectrum in Tuberous Sclerosis Complex (TSC): Using Biomarkers to Connect Preclinical Models to Early Intervention
    Drug Discovery and Development:
Drug Discovery and Development in ASD
    Epidemiology/Population Studies:
Leveraging Polygenic Risk Scores to Advance Autism Epidemiology
    International and Cross-Cultural Perspectives:
Cultural and Structural Factors Underlying Diagnostic and Service Disparities Among Racial/Ethnic Minority Children in the U.S.
    Service Delivery/Systems of Care:
Examining Experiences of Individuals in Communities from Diagnosis to Adulthood: Results from a Large State Needs Assessment Survey

 

11:30A-1:30P

Poster Sessions

    Adult Outcome:
Medical, Cognitive, Behavioral, Social, Adaptive, Vocational; Biomarkers (molecular, phenotypic, neurophysiological, etc); Communication and Language; Diagnostic, Behavioral, Sensory and Intellectual Screening and Assessment; Early Development (< 48 months); Education; Emotion; Epidemiology/Population Studies; Ethics; Family Issues and Stakeholder Experiences; Interventions - Non-pharmacologic - School-Age, Adolescent, Adult; Neuroanatomy; Neurochemistry; Neurophysiology/Electrophysiology; Sensory Physiology

 

12:30P-1:30P

Lunch Break (Box Lunches Provided)

 

12:30P-1:30P

INSAR Business Meeting

 

1:30P-3:30P

Concurrent Panel Sessions 

    Adult Outcome:
Medical, Cognitive, Behavioral, Social, Adaptive, Vocational: Autism, Sexuality and Romance: From a Better Understanding to Attuned Support
    Biomarkers (molecular, phenotypic, neurophysiological, etc):
Human and Animal Models: Impact of High-Risk Copy Number Variants on Brain Structure, Functional Connectivity, and Sexual Development. 
    Diagnostic, Behavioral, Sensory and Intellectual Screening and Assessment:
Clinical Presentation of ASD and Access to Care Among Girls
    Interventions - Non-pharmacologic - Infant, Toddler, and Preschool:
Lessons Learnt from the Field-Testing of the W.H.O. Caregiver Skills Training
    Rare Genetic Disorders:
Multi-Site, Direct Comparison of Three Autism Synaptopathies
    Technological Approaches:
Improving Access and Expanding the Reach of Clinical Care and Research in Autism Spectrum Disorder (ASD) through Innovations in Remote Delivery Methods

Contact Us

INSAR
International Society for Autism Research
400 Admiral Blvd. | Kansas City, MO 64106
USA

p. 816.595.4852
f.  816.472.7765
e. info@autism-insar.org

Follow Us

© 2018 INSAR | All Rights Reserved